Joke Spaargaren

Joke Spaargaren

Auto-generated profile, based on publicly available information

Joke Spaargaren

Society of Actuaries

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2004 in Nature Medicine
Verified
Journal Article
Closed access
LHLia van der Hoek
Lia van der Hoek
KPKrzysztof Pyrc
Krzysztof Pyrc
MJMaarten F Jebbink
Maarten F Jebbink
WVWilma Vermeulen-Oost
Wilma Vermeulen-Oost
RBRon J M Berkhout
Ron J M Berkhout
Ben BerkhoutBen Berkhout
Ben Berkhout

1 July 2002 in AIDS
Verified
Journal Article
Closed access
NDNicole Dukers-Muijrers
Nicole Dukers-Muijrers
JSJoke Spaargaren
Joke Spaargaren
RGRonald B. Geskus
Ronald B. Geskus
JBJos Beijnen
Jos Beijnen
RCRoel A. Coutinho
Roel A. Coutinho
HFHan S. A. Fennema
Han S. A. Fennema
Dramatic increases have occurred in sexually transmitted diseases (STD) and in sexual risk behaviour among homosexual men in Amsterdam and internationally. We investigated whether these trends indicate a resurgence of the HIV epidemic. HIV incidence was determined among homosexual attendees of an STD clinic in Amsterdam, who had participated in semi-annual anonymous unlinked cross-sectional HIV prevalence studies from 1991 to 2001. Stored HIV-seropositive samples were tested with a less-sensitive HIV assay and, if non-reactive, were further tested for the presence of antiretroviral drugs, indicative of the use of highly active antiretroviral therapy. Seropositive men who tested non-reactive on the less-sensitive assay and had not used antiretroviral drugs were classified as recently infected (< 170 days). Annual HIV incidence and its changes were examined. Among 3090 homosexual participants (median age 34 years), 454 were HIV infected, of whom 37 were recently infectioned. From 1991 to 2001 the overall incidence was 3.0 infections/100 person-years. Incidence increased over time (P = 0.02) and, strikingly, the increase was evident in older (≥ 34 years) men (P < 0.01), but not in the young. Of men recently infected, 84% (n = 31) were unaware of their infection and 70.3% (n = 26) had a concurrent STD. These 26 men reportedly had sex with a total of 315 men in the preceding 6 months. HIV incidence is increasing among homosexual attendees of an STD clinic. It is imperative to trace recently infected individuals, because they are highly infectious, and can thus play a key role in the spread of HIV.

1 November 2002 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
SMServaas A. Morré
Servaas A. Morré
LMLaura S. Murillo
Laura S. Murillo
JSJoke Spaargaren
Joke Spaargaren
HFHan S. A. Fennema
Han S. A. Fennema
APA. Salvador Peña
A. Salvador Peña

1 September 1995 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
JSJ Spaargaren
J Spaargaren
PGP L A Giesen
P L A Giesen
MJM P Janssen
M P Janssen
JVJ Voorberg
J Voorberg
GWG M Willems
G M Willems
JMJ A van Mourik
J A van Mourik
Factor VIII is a plasma protein which plays an essential role in the coagulation system. When assembled with the enzyme Factor IXa on a phospholipid membrane, it functions as a cofactor in the enzyme complex that cleaves the zymogen Factor X to Factor Xa. We studied the binding of both Factor VIII and the Factor VIII light chain to planar phospholipid bilayers consisting of 25% dioleoylphosphatidylserine and 75% dioleoylphosphatidylcholine (PSPC) by ellipsometry. Equilibrium-binding studies revealed that both Factor VIII and its light chain bind with high affinity to PSPC bilayers. The binding affinity of Factor VIII, with a dissociation constant Kd of 0.24 nM, was comparable with that of the Factor VIII light chain (Kd 0.49 nM). Maximal binding was 2.3 mmol of protein per mol of PSPC for Factor VIII and 7.1 mmol of protein per mol of PSPC for the Factor VIII light chain. Adsorption kinetics of both Factor VIII and its light chain conformed to the classical Langmuir adsorption model yielding dissociation constants calculated from the rates of adsorption that were similar to those obtained by equilibrium-binding studies. In contrast, measurements of rates of desorption revealed a deviation from those expected for a single class of binding sites. The desorption rate of Factor VIII increased with increasing residence time on the lipid membrane. This indicates transition of Factor VIII to a configuration with a lower binding affinity. As this time-dependent change in affinity could affect the validity of the measurement of binding parameters, in particular equilibrium-binding determinations carried out on a long timescale, binding affinity was also estimated from adsorption kinetics at half-maximal surface coverage, a relatively rapid procedure for the determination of the affinity. A Kd of 0.087 nM was obtained under these conditions. Measurement of equilibrium binding to small PSPC vesicles, a system in which equilibrium is rapidly attained, resulted in similar binding parameters (Kd = 0.13 nM and a maximal binding of 2.8 mmol of protein per mol of PSPC). These data confirm the results of equilibrium binding to planar bilayers. Taken together, our results indicate that Factor VIII, by means of its 80 kDa light chain, binds to PSPC bilayers with a dissociation constant below the concentration of Factor VIII in plasma and therefore may readily bind to exposed phospholipid membranes under physiological conditions.

1 April 2001 in Sexually Transmitted Infections
Verified
Journal Article
Open access
PDF file
BBB H B van Benthem
B H B van Benthem
JSJ Spaargaren
J Spaargaren
JHJ A R van Den Hoek
J A R van Den Hoek
JMJ Merks
J Merks
RCR A Coutinho
R A Coutinho
MPM Prins
M Prins
Objectives: To investigate the prevalence and risk factors of HSV-1 and HSV-2 antibodies in HIV infected women and the association between recurrent genital ulcerations and HIV disease progression in HSV-2 positive women. Methods: The presence of HSV antibodies was tested in 276 of the 487 women participating in a European cohort study of HIV infected women. Prevalence rate ratios described the association between HSV infection and its risk factors, using log binomial regression. Generalised estimating equations (GEE) analysis was performed to determine the impact of markers of HIV disease progression on recurrent genital ulcerations. Results: The prevalence of HSV-1 and HSV-2 antibodies was 76% (95% confidence interval (95% CI): 71–81) and 42% (95% CI: 36–50); 30% (95% CI: 24–35) of the women had antibodies against both HSV-1 and HSV-2. The prevalence of HSV-1 was 86% (95% CI: 80–92) in southern Europe compared with 69% (95% CI: 57–79) and 67% (95% CI: 55–77) in central and northern Europe (p=0.002). This geographical variation remained after adjustment for other risk factors. An increasing number of years of sexual activity (p=0.0002) and a history of prostitution (p=0.0001) were independently associated with HSV-2 prevalence. In HSV-2 positive women, symptomatic cases of HSV infection were minimal, but increased with decreasing CD4 count. Conclusion: In HIV infected women, the prevalence of HSV antibodies is high and symptomatic cases of HSV infection are minimal, but increase with decreasing CD4 count. HSV-2 but not HSV-1 was related to sexual behaviour (that is, a history of prostitution and the number of sexually active years) in this group of HIV infected women.

1 February 2000 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
LVLiesbeth Vogel
Liesbeth Vogel
JSJacobus H Sloos
Jacobus H Sloos
JSJoke Spaargaren
Joke Spaargaren
ISInge Suiker
Inge Suiker
LDLenie Dijkshoorn
Lenie Dijkshoorn